Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke

Inflammation following ischemic brain injury is correlated with adverse outcome. Preclinical studies indicate that treatment with acetylsalicylic acid + extended-release dipyridamole (ASA + ER-DP) has anti-inflammatory and thereby neuroprotective effects by inhibition of monocyte chemotactic protein...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Worthmann, Hans, Dengler, Reinhard, Schumacher, Helmut, Schwartz, Andreas, Eisert, Wolfgang G., Lichtinghagen, Ralf, Weissenborn, Karin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Molecular Diversity Preservation International (MDPI) 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3430258/
https://ncbi.nlm.nih.gov/pubmed/22942727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms13078670
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak